Investors Purchase Large Volume of Put Options on Merck & Co (MRK)
Shares of Merck & Co (NYSE:MRK) was the recipient of some unusual options trading activity on Monday. Investors acquired 14,851 put options on the company, Analyst Ratings Net reports. This is an increase of 151% compared to the typical volume of 5,924 put options.
Several analysts have recently commented on the stock. Analysts at Morgan Stanley upgraded shares of Merck & Co from an “equal weight” rating to an “overweight” rating in a research note to investors on Monday. They now have a $60.00 price target on the stock. Separately, analysts at TheStreet reiterated a “buy” rating on shares of Merck & Co in a research note to investors on Tuesday, January 21st. Finally, analysts at MKM Partners raised their price target on shares of Merck & Co from $59.00 to $64.00 in a research note to investors on Tuesday, January 14th. They now have a “buy” rating on the stock. One analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have assigned a buy rating to the company. Merck & Co currently has an average rating of “Hold” and an average target price of $53.81.
Merck & Co (NYSE:MRK) traded up 1.06% on Monday, hitting $52.53. The stock had a trading volume of 31,002,066 shares. Merck & Co has a 52-week low of $40.83 and a 52-week high of $53.44. The stock has a 50-day moving average of $50.04 and a 200-day moving average of $48.26. The company has a market cap of $153.5 billion and a price-to-earnings ratio of 34.93.
Merck & Co, Inc (NYSE:MRK) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.